Synairgen: shares soar of positive Covid-19 test results
The share price of Synairgen (LON: SNG), the AIM quoted respiratory drug discovery company, soared over 350% as it announced positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised Covid-19 patients.
The trial results showed that SNG001 greatly reduced the number of hospitalised Covid-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’. It also showed that patients who received…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Fundamental Asset Management
Buy any of our portfolios with our associates.
FIND OUT MORE
Previous article
Next article
More on Gamma Communications PLC
11/01/2021 · Company Insights
Several of AIM’s higher quality companies issued positive trading updates and in quick time after their…
08/09/2020 · Company Insights
There were a large number of announcements today, including fabulous results from a fast growing provider of…
More on MJ Hudson Group PLC
20/07/2020 · Company Insights
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
01/06/2020 · Company Insights
Video gaming continues to be in high demand, Dart sells its distribution business and a provider…
More on Pittards
30/09/2020 · Company Insights
Boohoo Group announced another set of fantastic results and, with a huge pile of cash at…
20/07/2020 · Company Insights
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Synairgen
20/07/2020 · Company Insights
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
18/06/2020 · Company Insights
Covid-19 test and vaccine developers were in the spotlight as they continue to make progress with…
More on Venture Life Group PLC
01/02/2021 · Company Insights
Bonkers Bargains covered in our update here appear to be doing all the right things and the…
20/11/2020 · Company Insights
The shares have gone nowhere since IPO but Directors are bizarrely allowed to exercise options and…
More Company Insights
26/02/2021
The first in our new series covering fast-growing small caps
Shares in David Beckham backed cannabis company soar on debut
Strong updates from beneficiaries of the move online
More on Gamma Communications PLC
More on MJ Hudson Group PLC
More on Pittards
More on Synairgen
More on Venture Life Group PLC
More Company Insights
